Envisagenics is a proud female and minority-led company, so we are thrilled to have our journey recognized in a recent El Pais article by Ana B. Nieto titled, "The two Latinos who were working with artificial intelligence and RNA long before everyone was talking about it." Before AI and RNA became industry buzzwords, our co-founders, Maria Luisa Pineda, PhD. and Martin Akerman, pioneered SpliceCore®, our platform that leverages AI to identify novel RNA therapeutics targets and develops targeted treatments for cancer and other diseases. This year, we marked our tenth anniversary with a celebration at Cold Spring Harbor Laboratory and are looking forward to the continued development of our pipeline with our recent Series B. Read the full article here: bit.ly/46Dir4H #Envisagenics #Oncology #Biotech #ArtificialIntelligence
Adelante!!! An important recognition for the team.
Felicidades!!! Justo reconocimiento al trabajo! Y lo mejor está por venir! Adelante!!
Love the name SpliceCore® Great branding!
Fantastic recognition!